SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
$17.4 -1.02 (-5.5375%)
Analysed SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) News Sources
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study Conducted in China
13-09-2026
yahoo.com
Summit’s Global Lung Cancer Trials Gain Credibility After Akeso’s Phase 3 Data, Says Guggenheim
26-08-2026
stocktwits.com
Summit Therapeutics (SMMT) Is Up 8.5% After New Phase III Biliary Cancer Data For Ivonescimab
27-08-2026
yahoo.com
Summit Therapeutics (SMMT) Published Phase III HARMONi Results In The Lancet Oncology
27-08-2026
yahoo.com
Summit Therapeutics Says It Is Beating Merck With Its Cancer Drug
03-09-2026
yahoo.com
Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold
03-09-2026
yahoo.com
Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress
07-09-2026
yahoo.com
Summit (SMMT) Says Akeso Reported a HARMONi-2 Overall-Survival Benefit Against Pembrolizumab
09-09-2026
yahoo.com
Summit Therapeutics shares gain after Jefferies upgrades stock to Buy
09-09-2026
advfn.com
Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
14-09-2026
biopharmadive.com
What is the current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is $17.4.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is $-1.02.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is -5.5375%.
What is the most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is .
SEC-8K** Filing Available For SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.